News & Updates

Rosacea poses risk of subsequent cardiovascular disease
Rosacea poses risk of subsequent cardiovascular disease
03 Oct 2021

Individuals with rosacea are at heightened risk of developing subsequent cardiovascular disease, as suggested in a study.

Rosacea poses risk of subsequent cardiovascular disease
03 Oct 2021
Screening, treatment for CVD lower in people with mental disorders
Screening, treatment for CVD lower in people with mental disorders
03 Oct 2021
Existing risk scores not enough to predict AF outcomes after pulmonary vein isolation
Existing risk scores not enough to predict AF outcomes after pulmonary vein isolation
02 Oct 2021
Major infections after PCI, CABG do not affect very long-term survival
Major infections after PCI, CABG do not affect very long-term survival
01 Oct 2021
The role of apixaban in managing venous thromboembolism
The role of apixaban in managing venous thromboembolism
01 Oct 2021

Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), carries a significant morbidity risk. Risk factors for VTE include surgery, hospitalization, pregnancy, contraceptive use, older age, overweight, and obesity. Dr Lee Yuh Shan, a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore, explains how newer drugs such as apixaban (Eliquis, Pfizer) address the challenges posed by conventional VTE management therapies.

The role of apixaban in managing venous thromboembolism
01 Oct 2021